Docking Studies of Benzimidazole Derivatives as Coenzyme-A Carboxylase (ACCase) Inhibitor

descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 2012Publisher:OMICS Publishing GroupJournal:Journal of AIDS & Clinical Research, volume 1 (eissn: 2155-6113,

Copyright policy )

Authors: Pradeep V Kore;

doi: 10.4172/scientificreports.439

Docking Studies of Benzimidazole Derivatives as Coenzyme-A Carboxylase (ACCase) Inhibitor

- Summary
- Metrics

Abstract

In these continuing efforts towards the development of disease modifying treatment for microbial diseases, we are targeting acetyl coenzyme-A carboxylase (ACCase) and it is essential for pathogen survival. In present study we reported the docking studies of substituted benzimidazole derivatives with acetyl coenzyme-A carboxylase inhibitor. Docking Studies of Benzimidazole Derivatives as Coenzyme-A Carboxylase (ACCase) Inhibitor

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average